Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
---|---|---|---|---|
Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
Börsenplätze | Performance | Management | Volatilität | Watchlist |
Historisch | Benchmark | Sharpe Ratio | ||
Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
1’047.86 EUR | EUR | % |
---|
Vortag | EUR | Datum | 20.12.2024 |
Anzeige
Name | ISIN | Performance | |
---|---|---|---|
21Shares Stellar ETP | CH1109575535 | 354.75% | |
21Shares Ripple XRP ETP | CH0454664043 | 334.40% | |
21Shares Stacks Staking ETP | CH1258969042 | 227.84% | |
21Shares Algorand ETP | CH1146882316 | 196.18% | |
21Shares Cardano ETP | CH1102728750 | 178.10% | |
21Shares Sui Staking ETP | CH1360612159 | 119.60% | |
21Shares Injective Staking ETP | CH1360612134 | 14.29% | |
21Shares Immutable ETP | CH1360612142 | -8.25% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 429.63% | |
21Shares Stellar ETP | CH1109575535 | 379.12% | |
21Shares Aave ETP | CH1135202120 | 254.88% | |
21Shares Algorand ETP | CH1146882316 | 170.06% | |
21Shares Cardano ETP | CH1102728750 | 161.84% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 297.92% | |
21Shares Stellar ETP | CH1109575535 | 244.49% | |
21Shares Aave ETP | CH1135202120 | 198.89% | |
21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 168.42% | |
21Shares Binance BNB ETP | CH0496454155 | 124.66% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Solana staking ETP | CH1114873776 | 1’444.52% | |
21Shares Ripple XRP ETP | CH0454664043 | 547.74% | |
21Shares Bitcoin Core ETP | CH1199067674 | 464.56% | |
21Shares Bitcoin ETP | CH0454664001 | 450.29% | |
21Shares Stellar ETP | CH1109575535 | 439.59% |
Fundamentaldaten
Valor | |
ISIN | LU2320788479 |
Emittent | Symbiotics |
Aufgelegt in | Luxembourg |
Auflagedatum | 09.04.2021 |
Kategorie | Anleihen Sonstige |
Währung | EUR |
Volumen | |
Depotbank | CACEIS Bank, Luxembourg Branch |
Geschäftsjahresende | 31.03. |
Berichtsstand | 09.01.2025 |
Anlagepolitik
So investiert der Symbiotics SICAV II - Emerging Impact Bond Fund B EUR Fonds: The main objective of the Sub-Fund is to provide a Money Market Plus risk/return profile to investors resulting from economic value creation at the base of the pyramid mostly in EFMs. In particular, the objective of the Sub-Fund is to make sustainable investment within the meaning of article 9 of SFDR by focusing on businesses and projects which target LMIHs as well as MSMEs populations, with a view to fostering inclusive development impact for its clientele and long term value creation through sustainable principles (environment, social, governance) for its investors.
ETP Performance: Symbiotics SICAV II - Emerging Impact Bond Fund B EUR Fonds
Performance 1 Jahr | 1.01 | |
Performance 2 Jahre | - | |
Performance 3 Jahre | - | |
Performance 5 Jahre | - | |
Performance 10 Jahre | - |